REQUEST A DEMO
Total
USD $0.00
Search more companies

Gamot Api Pte. Ltd. (Singapore)

Main Activities: Offices of Other Holding Companies
Full name: Gamot Api Pte. Ltd. Profile Updated: September 30, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Gamot Api Pte. Ltd. is based in Singapore. The head office is in Singapore. It operates in the Offices of Other Holding Companies sector. The enterprise was incorporated on July 28, 2020. Its total assets grew by 542.35% over the same period.

Headquarters
9 Temasek Boulevard, #12-01/02 Suntec Tower Two, Singapore
Singapore; Singapore; Postal Code: 038989

Contact Details: Purchase the Gamot Api Pte. Ltd. report to view the information.

Basic Information
Outstanding Shares:
Purchase the Gamot Api Pte. Ltd. report to view the information.
Financial Auditors:
Purchase the Gamot Api Pte. Ltd. report to view the information.
Incorporation Date:
July 28, 2020
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Company Secretary
Ownership Details
Purchase this report to view the information.
78.11%
Purchase this report to view the information.
11.73%
Purchase this report to view the information.
10.16%
Purchase this report to view the information.
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Gamot Api Pte. Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Total assets
542.35%
Total equity
580.23%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?